- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid biomarkers of Alzheimer’s disease
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 4, Issue 1, Pages 51-63
Publisher
Future Medicine Ltd
Online
2010-02-03
DOI
10.2217/bmm.09.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly
- (2009) Anne M. Fagan et al. ANNALS OF NEUROLOGY
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
- (2009) Barbara J. Snider et al. ARCHIVES OF NEUROLOGY
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
- (2009) John C. Morris et al. ARCHIVES OF NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
- (2009) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Safety of Lumbar Puncture Procedures in Patients with Alzheimers Disease
- (2009) E. Peskind et al. Current Alzheimer Research
- Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment
- (2009) Johannes Kornhuber et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Validation of Alzheimer’s disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer’s Disease Neuroimaging Initiative (E-ADNI)
- (2009) Katharina Buerger et al. EXPERIMENTAL GERONTOLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
- (2009) Volker Welge et al. JOURNAL OF NEURAL TRANSMISSION
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
- (2009) Richard J. Perrin et al. NATURE
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
- (2009) Joseph L. Price et al. NEUROBIOLOGY OF AGING
- Relationships between biomarkers in aging and dementia
- (2009) W. J. Jagust et al. NEUROLOGY
- The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium
- (2008) Giovanni B. Frisoni et al. Alzheimers & Dementia
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
- (2008) Michael Ewers et al. BRAIN
- Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats
- (2008) Changping Yao et al. BRAIN INJURY
- PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
- (2008) J. Koivunen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Biomarkers of Alzheimer's disease
- (2008) Rebecca Craig-Schapiro et al. NEUROBIOLOGY OF DISEASE
- Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
- (2008) John S. K. Kauwe et al. NEUROGENETICS
- Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
- (2008) J. S. K. Kauwe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid- Dynamics Correlate with Neurological Status in the Injured Human Brain
- (2008) D. L. Brody et al. SCIENCE
- Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
- (2007) Piotr Lewczuk et al. NEUROBIOLOGY OF AGING
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started